Elijah Songok at the Kenya Medical Research Institute hopes to better understand preliminary findings from studies of sex workers that natural resistance to HIV may be linked to genetic markers for type 2 diabetes.
Stephen Johnston of Arizona State University will investigate whether HIV causes deficient protein synthesis in infected cells. This knowledge could be used to stimulate normal human T cells to destroy infected cells based on these aberrant host antigens.
Using genome scans, Alfred Roca of the University of Illinois will test the possibility that isolated African populations have been repeatedly exposed to chimpanzee immunodeficiency viruses, and have evolved resistance to HIV. Ascertaining whether they display resistance to HIV could lead to new ways to fight HIV in other populations.
Because malnutrition, micronutrient deficiency and parasitic worm infection are all major risk factors for developing visceral leishmaniasis, Dinesh Mondal of International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B) will study if VL development can be prevented in asymptomatic patients through nutritional supplements of vitamin A, zinc and iron, as well as anti-helminth treatment.
Roly Gosling of the London School of Hygiene and Tropical Medicine in the United Kingdom will conduct a pilot study in Tanzania to test whether malaria cases can be contained by treating the households and immediate neighbors of those diagnosed with malaria. The goal of this research is to understand whether such community approaches can clear asymptomatic carriers and eliminate parasites within these "hotspots."
Sandhya Visweswariah of the Indian Institute of Science in India will generate a mouse model for studying secretory diarrhea, which causes significant mortality in young children. Secretory diarrhea is often caused by the bacterium Escherichia coli, which produces a toxin that binds to a cell surface receptor (the guanylyl cyclase C receptor) in the gastrointestinal tract thereby causing diarrhea. They will genetically engineer a mouse in which they can hyperactivate this receptor specifically in intestinal cells to potentially trigger secretory diarrhea.
Lijuan Yuan of Virginia Polytechnic Institute and State University in collaboration with Sylvia Becker-Dreps and Andrea Azcarate-Peril from University of North Carolina at Chapel Hill in the U.S. and Samuel Vilchez from University of Nicaragua will develop a pig model with impaired intestinal function and altered types of gut microbes to mimic the condition of many children in developing countries who do not respond to vaccines against rotavirus infection, which causes infectious diarrhea.
Kim Thomson of the University of Reading in the United Kingdom will develop a combined metric to account for the impact of both human and animal diseases on poverty. This one health metric will incorporate two recognized poverty metrics: one that measures the poverty impact of individual livestock diseases, and the other that measures the poverty impact of human disease, which reflects both quantity and quality of life years. This will enable comparisons of poverty impact both between different diseases and across different populations.
Syed Abbas of the Public Health Foundation of India in India, with colleagues Manish Kakkar and Krishna Rao, will adapt a Multi-Criteria Decision Analysis approach to integrate different perspectives from the animal, environment, and human health sectors on the impact and intervention scenarios of zoonotic diseases, which infect animals and humans. The impact of a single disease and the effects of a specific intervention strategy affect the sectors in different ways.
Christopher Huston of the University of Vermont in the U.S. will use a calf model to develop effective treatments for the intestinal parasite Cryptosporidium, which causes severe diarrhoea in both humans and animals. Cryptosporidiosis can be life threatening, and current treatments are ineffective. They have performed a cell- based screen of existing human drugs and identified candidates for treating Cryptosporidiosis that need testing in preclinical animal models.